Age-related sarcopenia begins around age 35 and accelerates during perimenopause and menopause, primarily due to declining estrogen levels
How lower, capped-dose GLP-1 + GIP signaling supports long-term metabolic resilience with improved tolerability
This is by far the biggest factor
"The hard part was getting the medication when I needed it
The main difference is that Zepbound targets two hormones (GLP-1 and GIP) while Saxenda targets only GLP-1, and Zepbound requires weekly injections versus daily shots for Saxenda
Wu T, Zhao Y, Wang Z, Song Q, Wang Z, Xu Q, Wang Y, Wang L, Zhang Y, Feng C (2018) -1, 3-Glucan recognition protein 3 activates the prophenoloxidase system in response to bacterial infection in Ostriniafurnacalis Guene